Contact us
Home / News Center

News Center

Filters
Filters
Category
Search
Show (62)
Cancel
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
Business

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

Bora manufactures more than 20 commercial products for GSK at

Bora-Zhunan-2-r9rm43l1jaffg866ioruef5763z1vbjprjfkrv6o6k
Business, Investors

Bora Pharmaceuticals’ Zhongli Facility Approved as a Bonded Factory, Advancing Supply Chain Efficiency

Taipei, Taiwan, February 23, 2026 – Bora Pharmaceuticals Co., Ltd.

Bora-Zhunan-2-r9rm43l1jaffg866ioruef5763z1vbjprjfkrv6o6k
Business

Bora Pharmaceuticals to Sponsor “Berkeley Dialogue” in Taipei, Advancing the Biopharma R&D and Supply Chain

Bora to discuss a recent collaboration with Therapi AI, highlighting

cropped-image (18)
Business

Bora Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

Taipei, Taiwan, January 22, 2026 – Bora Pharmaceuticals Co., Ltd.

ADR Web
Business, Investors

OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX

NEW YORK, (January 8, 2026) –OTC Markets Group Inc. (OTCQX:

Bora Web Cover Banner (3)
Business

Bora Pharmaceuticals Advances Governance and Carbon Reduction to Power Its Sustainability Ambition and Enhance Global CDMO Capabilities

Taipei, Taiwan, (December 12, 2025) – Bora Pharmaceuticals Co., Ltd.

Bora + Corealis
Business

Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development

Partnership creates simplified pathway from early development to commercial launch

bora2
Business

Bora Pharmaceuticals Marks Five Years in Mississauga, Canada, Strengthening Its Commitment to Onshore and Global CDMO Excellence 

Milestone reflects the company’s continued impact in providing global pharmaceutical

Bora Web Cover Banner
Business, Events

Bora Company Presentation at 44th Annual J.P. Morgan Healthcare Conference

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) today announced

Bora Web Cover Banner (1)
Business, Business

Bora Strengthens U.S. Rare Disease Portfolio With Upsher-Smith Launch of KYMBEE™ (Deflazacort Tablets) for Duchenne Muscular Dystrophy

Maple Grove, Minnesota, December 1, 2025 – Bora Pharmaceuticals Co.,

Canadas Safest New Employer web
Business

Bora Pharmaceuticals Wins Canada’s Safest New Employer Award

MISSISSAUGA (October, 2025) — Bora Pharmaceuticals Co., Ltd. (“Bora” or

Bora Pharmaceuticals Wins World Finance Sustainability Award 2025 (1)
Business

Bora Pharmaceuticals Wins Biotech Company of the Year Award 

Leading CDMO selected amongst hundreds of worldwide nominations by Biotech